Showing 801 - 820 results of 120,802 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 0.97s Refine Results
  1. 801
  2. 802
  3. 803
  4. 804
  5. 805
  6. 806

    Housing conditions specifically impaired long-term SRM (mean±SEM): A) Rats in group housing displayed a significant decrease in SIT during the second 5 min encounter (A2, empty bars) compared to the first (A1, gray bars), regardless of the time interval between the encounters. by Hadar Shahar-Gold (283031)

    Published 2013
    “…D) Rats from group housing (gray bars, n<i> = </i>10) and socially isolated rats (empty bars, n = 10) similarly retained object recognition memory for 120 min following a single 5 min exposure. Both groups showed a significant decrease in investigation time during the second exposure to an object (A2), compared with the first exposure (A1) 120 min earlier and compared with exposure to a novel object (B) 30 min later. …”
  7. 807
  8. 808
  9. 809

    Nilotinib decreases HEI-193 cell viability in a time-, dose-, and growth condition- dependent manner. by Nesrin Sabha (127278)

    Published 2013
    “…(B) HEI-193 grown in PDGF media were treated with 0, 3, 5, 10 or 20 µM nilotinib up to 5 days. Trypan blue viability assay shows decreased number of viable cells at 5 days in 3 µM nilotinib, compared to vehicle shown, mean and SD of six technical replicates. …”
  10. 810
  11. 811

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Data represent mean±S.D. F. Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. …”
  12. 812
  13. 813

    Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner. by Shahin Ranjbar (66979)

    Published 2013
    “…Blocking TNF (at 2 ug/ml or 5 ug/ml) or IL-6 (5 ug/ml) significantly decreased virus replication (*, p<0.05) as compared to the same concentrations of an IgG<sub>1</sub> control antibody. …”
  14. 814
  15. 815
  16. 816
  17. 817

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  18. 818
  19. 819
  20. 820